日本人における黄斑疾患の臨床経過に関するコホート研究

基本情報

NCT ID

NCT02081339

ステータス

不明

試験のフェーズ

-

試験タイプ

観察

目標被験者数

1,000

治験依頼者名

Kyoto University, Graduate School of Medicine

概要

Recent clinical introduction of anti-vascular endothelial growth factor agents may change the clinical course of macular diseases, including age-related macular degeneration (AMD), polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation (RAP), central serous chorioretinopathy (CSC), myopic choroidal neovascularization (CNV), retinal vein occlusion (RVO), diabetic macular edema (DME), and so forth. Patients with such macular diseases are registered and and are followed up for 5 years with appropriate treatment for each patient. By the analysis of the correlation between initial examinations and final visual acuity, factors associated with good visual prognosis will be elucidated.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)